Loading...

APC anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_APC_090507
C57BL/6 mouse splenocytes stained with 30-F11 APC
  • 30-F11_APC_090507
    C57BL/6 mouse splenocytes stained with 30-F11 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
103111 25 µg $33
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103112 100 µg $94
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Gavin KM, et al. 2018. Front Endocrinol (Lausanne). 9:276. PubMed
  2. Wang L, et al. 2018. Bone Res. 6:22. PubMed
  3. Cha JH et al. 2018. Molecular cell. 71(4):606-620 . PubMed
  4. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  5. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  6. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  7. Jiang Z, et al. 2021. J Clin Invest. 131: . PubMed
  8. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  9. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  10. Kuo PC, et al. 2021. Brain Commun. 3:fcab187. PubMed
  11. Nigam S, et al. 2020. Mol Imaging Biol. 22:685. PubMed
  12. Yang D, et al. 2022. Cell. 185:1905. PubMed
  13. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  14. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  15. Almada AE, et al. 2021. Cell Reports. 34(4):108656. PubMed
  16. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  17. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  18. Jaiswal AK, et al. 2020. Immunobiology. 225:151956. PubMed
  19. Cayre S, et al. 2020. Development. 147:00:00. PubMed
  20. Díaz NM, et al. 2020. Invest Ophthalmol Vis Sci. 61:37:00. PubMed
  21. Mourao L, et al. 2019. Sci Rep. 0.991666667. PubMed
  22. Oetjen LK et al. 2017. Cell. 171(1):217-228 . PubMed
  23. Testini C, et al. 2019. EMBO Rep. 20:e47845. PubMed
  24. Gao Q, et al. 2019. J Exp Med. 216:688. PubMed
  25. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  26. Ahmed M, et al. 2016. Development. 143: 1663 - 1673. PubMed
  27. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  28. Lim JT, et al. 2020. Mol Cancer Ther. 1809:19. PubMed
  29. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  30. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  31. Kang I, et al. 2012. Blood. 119:3295. PubMed
  32. Rosa FF, et al. 2020. Bio Protoc. 10:e3619. PubMed
  33. Wang Y, et al. 2021. J Bone Oncol. 30:100386. PubMed
  34. Lu L, et al. 2022. Sci Rep. 12:931. PubMed
  35. Parhiz H, et al. 2022. J Control Release. 344:50. PubMed
  36. Yanagida K, et al. 2020. Dev Cell. 779:52. PubMed
  37. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  38. Larouche JA, et al. 2021. eLife. 0.416666666666667. PubMed
  39. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  40. Barberio AE, et al. 2020. ACS Nano. 14:11238. PubMed
  41. Chiche A, et al. 2016. Oncogene. 10.1038/onc.2016.396. PubMed
  42. Eastman A, et al. 2016. J Immunol . 194: 5999-6010. PubMed
  43. Engelbrecht E, et al. 2020. eLife. 9:e52690.. PubMed
  44. Hays C, et al. 2020. eLife. 8:e48772.. PubMed
  45. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  46. Chen J, et al. 2022. Nat Commun. 13:6759. PubMed
  47. Wang S, et al. 2022. Front Immunol. 13:869061. PubMed
  48. Zhang Y, et al. 2022. Cancers (Basel). 14:. PubMed
  49. Barwe SP, et al. 2022. J Clin Med. 11:. PubMed
  50. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  51. Yu X, et al. 2021. Nature. 594:560. PubMed
  52. Sato S, et al. 2021. Int J Mol Sci. 22:. PubMed
  53. Oliva Chávez AS, et al. 2021. Nat Commun. 12:3696. PubMed
  54. Strunz M, et al. 2020. Nat Commun. 2.929861111. PubMed
  55. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  56. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  57. Wosczyna MN, et al. 2021. Cell Stem Cell. 28(7):1323-1334.e8. PubMed
  58. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  59. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  60. Motoyama S, et al. 2020. Cells. :9. PubMed
  61. Jin X, et al. 2019. Mol Cell. 73:22:00. PubMed
  62. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  63. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  64. Romagnoli M, et al. 2020. Development. 147:. PubMed
  65. Li Q, et al. 2021. Brain Behav Immun. 94:437. PubMed
  66. Wang X, et al. 2022. Nat Aging. 2:155. PubMed
  67. Wang T, et al. 2020. Blood Sci. 2:79. PubMed
  68. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  69. Amouyal C, et al. 2020. EBioMedicine. 58:102895. PubMed
  70. Liu L, et al. 2015. Neurol Neuroimmunol Neuroinflamm. 2: 174. PubMed
  71. Hyatt L, et al. 2014. PLoS One. 9:109072. PubMed
  72. Pelletier A, et al. 2012. J Immunol. 188:5561. PubMed
  73. Herting CJ, et al. 2019. Brain. 142:3834. PubMed
  74. Romagnoli M, et al. 2019. Stem Cell Reports. 1.077083333. PubMed
  75. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  76. De S, et al. 2018. Development. 145. PubMed
  77. Xiao X, et al. 2019. Cell Discov. 5:2. PubMed
  78. Mauduit O, et al. 2022. Front Immunol. 13:1011125. PubMed
  79. Chen Z, et al. 2022. Theranostics. 12:6242. PubMed
  80. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  81. Bourn JR, et al. 2021. Cancer Lett. 503:75. PubMed
  82. Khateb M, et al. 2022. Cell Rep. 40:111219. PubMed
  83. Xu Q, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  84. Liu K, et al. 2022. Theranostics. 12:639. PubMed
  85. Sato Y, et al. 2021. J Clin Invest. Online ahead of print. PubMed
  86. Lafkas D, et al. 2013. J Cell Biol. 203:47. PubMed
  87. Ma S, et al. 2021. Cell Reports. 34(6):108726. PubMed
  88. Ankawa R, et al. 2021. Developmental Cell. . PubMed
  89. An J,et al. 2017. Sci Rep.. 10.1038/s41598-017-13629-0. PubMed
  90. Wosczyna MN et al. 2019. Cell Rep. 27(7):2029-2035 . PubMed
  91. Maston LD, et al. 2017. Am J Physiol Lung Cell Mol Physiol. 312:L609. PubMed
  92. Bresson L, et al. 2018. Development. 145. PubMed
  93. Charmsaz S, et al. 2017. Leukemia. 31:1779. PubMed
  94. Sambasivan R, et al. 2011. Development. 138:3647. PubMed
  95. Hu EY, et al. 2021. Blood Adv. 5:3152. PubMed
  96. Palathingal Bava E, et al. 2022. JCI Insight. 7:. PubMed
  97. Shcherbina A, et al. 2020. Cell Rep. 32:107964. PubMed
  98. Wu J, et al. 2020. Immunity. 53:115. PubMed
  99. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  100. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  101. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  102. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  103. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  104. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  105. Zheng B, et al. 2018. J Hematol Oncol. 11:16. PubMed
  106. Pal B, et al. 2017. Nat Commun.. 10.1038/s41467-017-01560-x. PubMed
  107. Fischer A, et al. 2022. Nat Immunol. 23:518. PubMed
  108. Hu J, et al. 2022. Cell Mol Neurobiol. . PubMed
  109. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  110. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  111. Yuan Z, et al. 2018. Emerg Microbes Infect. 7:59. PubMed
  112. Hou M, et al. 2020. Stem Cell Res Ther. 11:55. PubMed
  113. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  114. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  115. Thinard R, et al. 2022. Pharmaceutics. 14:. PubMed
  116. Yang H, et al. 2022. Nutrients. 14:. PubMed
  117. Hu J, et al. 2022. J Neuroinflammation. 19:71. PubMed
  118. Pezoldt J, et al. 2022. Nat Commun. 13:7227. PubMed
  119. Jia Q, et al. 2021. Theranostics. 4699:11. PubMed
  120. Paiva-Oliveira E, et al. 2017. Histochem Cell Biol. 10.1007/s00418-017-1556-6. PubMed
  121. Dudek KA, et al. 2020. Proc Natl Acad Sci U S A. 117:3326. PubMed
  122. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
  123. Crooks SD, et al. 2022. Immunohorizons. 6:705. PubMed
  124. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  125. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  126. Koren E, et al. 2022. Nat Commun. 13:4628. PubMed
  127. Bauer T, et al. 2021. Life (Basel). 11:. PubMed
  128. Li P, et al. 2022. EMBO Mol Med. 14:e14511. PubMed
  129. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  130. Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed
  131. Wang C, et al. 2011. Hepatology. 55:108. PubMed
  132. Sim S, et al. 2016. PLoS One. 11: 0152485. PubMed
  133. Mangum L, et al. 2016. Toxicol Sci. 150: 169 - 177. PubMed
  134. Mizuno T, et al. 2017. Sci Rep. 7:42714. PubMed
  135. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  136. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  137. Kaur A, et al. 2019. Cancer Discov. 9:64. PubMed
  138. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  139. Zhou G, et al. 2019. FASEB J. 33:11396. PubMed
  140. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  141. Yang Y, et al. 2022. Elife. 11:. PubMed
  142. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  143. Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed
  144. Scur M, et al. 2022. Nat Commun. 13:7272. PubMed
  145. Xi W, et al. 2021. Stem Cell Res Ther. 167:12. PubMed
  146. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  147. Dawson CA, et al. 2021. Nature Protocols. 16(4):1907-1935. PubMed
  148. Seki T, et al. 2015. J Biochem. 158: 485 - 495. PubMed
  149. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  150. Tu WL, et al. 2018. Am J Pathol. 188:2688. PubMed
  151. Chiche A, et al. 2019. Breast Cancer Res. 21:13. PubMed
  152. Feng J,et al. 2017. Nat Commun. . 10.1038/s41467-017-01056-8. PubMed
  153. Limbad C, et al. 2022. iScience. 25:103848. PubMed
  154. Chiang HY, et al. 2022. Nat Commun. 13:874. PubMed
  155. Aguilera M, et al. 2021. Int J Mol Sci. 22:. PubMed
  156. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  157. Ding X, et al. 2015. J Immunol. 194:4251. PubMed
  158. Wang L, et al. 2015. Cancer Immunol Res. 3: 1030-1041. PubMed
  159. Mueller A, et al. 2016. Nature. 540:276-279. PubMed
  160. Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed
  161. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  162. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  163. Mori A, et al. 2021. Cells. :10. PubMed
  164. Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed
  165. Shi R, et al. 2019. J Cancer. 10:367. PubMed
  166. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  167. Usmani SM et al. 2019. Cell host & microbe. 25(1):73-86 . PubMed
  168. Zasłona Z, et al. 2017. Am J Physiol Lung Cell Mol Physiol. 312:L855. PubMed
  169. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  170. Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed
  171. Dion-Albert L, et al. 2022. Nat Commun. 13:164. PubMed
  172. Long JT, et al. 2022. Elife. 11:. PubMed
  173. Zhang Z, et al. 2021. Exp Dermatol. 30:102. PubMed
  174. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  175. Yang Y, et al. 2021. Cell Reports. 34(10):108822. PubMed
  176. Taya M, et al. 2020. Endocr Relat Cancer. 27:261. PubMed
  177. Cai B, et al. 2020. Cell Metabolism. 31(2):406-421.e7.. PubMed
  178. Lu Y, et al. 2020. Immunity. 52:782. PubMed
  179. Toyama K, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1392. PubMed
  180. Qiao S, et al. 2019. J Neuroinflammation. 16:4. PubMed
  181. Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed
  182. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  183. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  184. Elias S, et al. 2015. PLoS Biol. 13:1002142. PubMed
  185. Deng P, et al. 2021. Cell Stem Cell. 28(6):1057-1073.e7. PubMed
  186. Zhang Y, et al. 2020. Cancer Res. 80:3345. PubMed
  187. Carmody C et al. 2019. Endocrinology. 160(5):1205-1222 . PubMed
  188. Fu NY, et al. 2018. Dev Cell. 47:629. PubMed
  189. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  190. Yeo SK, et al. 2020. eLife. 9:e58810.. PubMed
  191. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  192. Hoover AR, et al. 2022. Clin Transl Med. 12:e937. PubMed
  193. Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed
  194. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  195. Sroor HM, et al. 2019. Sci Rep. 9:20217. PubMed
  196. Chen PY, et al. 2019. Nat Metab. 0.675. PubMed
  197. Cao Y, et al. 2019. Nat Commun. 10:1280. PubMed
  198. Liu L et al. 2018. Cell stem cell. 23(4):544-556 . PubMed
  199. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  200. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  201. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  202. Cai T, et al. 2022. Nat Commun. 13:2228. PubMed
  203. Kim KS, et al. 2022. JCI Insight. 7:. PubMed
  204. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  205. Vaas M, et al. 2016. J Cereb Blood Flow Metab. 10.1177/0271678X16676825. PubMed
  206. Wong J, et al. 2016. Sci Signal. 9: ra103. PubMed
  207. Yuan Z, et al. 2016. J Virol. 90: 7728 - 7739. PubMed
  208. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  209. Jiang Y, et al. 2015. MBio. 6: e01426-15. PubMed
  210. Roberts L, et al. 2014. Infect Immun . 82:2504. PubMed
  211. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  212. Ouadah Y, et al. 2019. Cell. 179:403. PubMed
  213. Piotrowski AF, et al. 2018. Oncoimmunology. 7:e1445951. PubMed
  214. Sarshad AA, et al. 2018. Mol Cell. 71:1040. PubMed
  215. Gopalakrishnapillai A, et al. 2021. Cancers (Basel). 13:. PubMed
  216. Liu G, et al. 2022. Theranostics. 12:2248. PubMed
  217. Piirainen S, et al. 2021. Glia. 69:2459. PubMed
  218. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  219. Li H, et al. 2022. iScience. 25:104481. PubMed
  220. Cayre S, et al. 2020. Development. . PubMed
  221. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  222. Pal B, et al. 2021. Breast Cancer Res. 23:69. PubMed
  223. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  224. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  225. Koh BI, et al. 2020. Nat Commun. 3.143055556. PubMed
  226. Ren D, et al. 2020. Am J Cancer Res. 2851:10. PubMed
  227. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  228. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  229. Peltzer N, et al. 2018. Nature. 557:112. PubMed
  230. Qu Y, et al. 2020. Cell Reports. 32(1):107873. PubMed
  231. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  232. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  233. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  234. Bravo JI, et al. 2021. STAR Protocols. 2(2):100406. PubMed
  235. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  236. Kabir AU, et al. 2018. JCI Insight. 3. PubMed
  237. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  238. Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
  239. Liu C, et al. 2022. Nat Commun. 13:1989. PubMed
  240. Saber M, et al. 2021. J Neurotrauma. 38:2862. PubMed
  241. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  242. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  243. Deets KA, et al. 2021. Elife. 10:. PubMed
  244. Murray CW, et al. 2022. Nat Commun. 13:1090. PubMed
  245. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  246. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  247. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
RRID
AB_312976 (BioLegend Cat. No. 103111)
AB_312977 (BioLegend Cat. No. 103112)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS UV™ 395 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05/14/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account